FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4387500514> ?p ?o ?g. }

• W4387500514 abstract "Objective Since its discovery as an antioxidant, melatonin has been increasingly recognized for its therapeutic potential beyond sleep disturbances in neurodegenerative disorders. This study aims to evaluate efficacy of various melatonin doses, treatment durations, and formulations, in alleviating motor symptoms and sleep disturbances in Parkinson’s disease, the second most common neurodegenerative disorder worldwide. Methods PubMed, Cochrane Library, ClinicalTrials.gov and other databases were systematically searched to retrieve randomized controlled trials (RCTs) administrating melatonin to Parkinson’s disease patients until June 10th, 2023. Outcomes including Unified Parkinson Disease Rating Scale (UPDRS) scores and Pittsburgh Sleep Quality Index (PSQI) scores, were pooled and reported as mean differences (MD) with 95% confidence intervals (CIs). Meta-analysis was performed using an inverse variance random-effects model in Review Manager 5.4 software. Trial Sequential Analysis was performed to avoid false-positive results from random errors. Results Five RCTs with a total of 155 patients were included. Statistically significant reductions in UPDRS total scores were observed in groups receiving Melatonin ≥10 mg/day (MD = −11.35, 95% CI: −22.35 to −0.35, I 2 = 0%, p = 0.04) and immediate release formulations (MD = −11.35, 95% CI: −22.35 to −0.35, I 2 = 0%, p = 0.04). No significant effects on individual UPDRS II, III, and IV scores were observed, regardless of melatonin dosage and treatment duration. Moreover, significant improvements in PSQI scores were observed with only immediate-release melatonin formulations (MD = −2.86, 95% CI: −4.74 to −0.97, I 2 = 0%, p = 0.003). Conclusion Melatonin ≥10 mg/day for a minimum duration of ≥12 weeks in immediate-release formulations consistently demonstrated significant therapeutic potential in improving motor symptom and sleep disturbances in Parkinson disease. However, further trials are warranted to investigate its impact when initiated early in the disease course to fully explore its true therapeutic potential. Systematic review registration Unique identifier: CRD42023427491 (PROSPERO)." @default.
• W4387500514 created "2023-10-11" @default.
• W4387500514 creator A5016606411 @default.
• W4387500514 creator A5034379204 @default.
• W4387500514 creator A5081920815 @default.
• W4387500514 date "2023-10-10" @default.
• W4387500514 modified "2023-10-12" @default.
• W4387500514 title "Significant potential of melatonin therapy in Parkinson’s disease – a meta-analysis of randomized controlled trials" @default.
• W4387500514 cites W1534181333 @default.
• W4387500514 cites W1570607043 @default.
• W4387500514 cites W1608419697 @default.
• W4387500514 cites W1948315762 @default.
• W4387500514 cites W1968601014 @default.
• W4387500514 cites W1975426825 @default.
• W4387500514 cites W1983478689 @default.
• W4387500514 cites W1985031521 @default.
• W4387500514 cites W1998571654 @default.
• W4387500514 cites W2005182361 @default.
• W4387500514 cites W2005538581 @default.
• W4387500514 cites W2008560062 @default.
• W4387500514 cites W2011469467 @default.
• W4387500514 cites W2015934269 @default.
• W4387500514 cites W2020538074 @default.
• W4387500514 cites W2020621560 @default.
• W4387500514 cites W2022052618 @default.
• W4387500514 cites W2025517512 @default.
• W4387500514 cites W2026484597 @default.
• W4387500514 cites W2041168627 @default.
• W4387500514 cites W2043646512 @default.
• W4387500514 cites W2049357869 @default.
• W4387500514 cites W2055988844 @default.
• W4387500514 cites W2056882404 @default.
• W4387500514 cites W2059352599 @default.
• W4387500514 cites W206177870 @default.
• W4387500514 cites W2062280245 @default.
• W4387500514 cites W2065515412 @default.
• W4387500514 cites W2073777605 @default.
• W4387500514 cites W2075136248 @default.
• W4387500514 cites W2075262874 @default.
• W4387500514 cites W2086059108 @default.
• W4387500514 cites W2087744632 @default.
• W4387500514 cites W2093200944 @default.
• W4387500514 cites W2094082830 @default.
• W4387500514 cites W2098619885 @default.
• W4387500514 cites W2104511643 @default.
• W4387500514 cites W2130367817 @default.
• W4387500514 cites W2131638502 @default.
• W4387500514 cites W2132534755 @default.
• W4387500514 cites W2140978740 @default.
• W4387500514 cites W2142059781 @default.
• W4387500514 cites W2145234674 @default.
• W4387500514 cites W2145266235 @default.
• W4387500514 cites W2151487996 @default.
• W4387500514 cites W2151944611 @default.
• W4387500514 cites W2156051064 @default.
• W4387500514 cites W2157409627 @default.
• W4387500514 cites W2158817614 @default.
• W4387500514 cites W2160666444 @default.
• W4387500514 cites W2163141580 @default.
• W4387500514 cites W2165834747 @default.
• W4387500514 cites W2170892587 @default.
• W4387500514 cites W2523211502 @default.
• W4387500514 cites W2620457364 @default.
• W4387500514 cites W2767931992 @default.
• W4387500514 cites W2771043801 @default.
• W4387500514 cites W2790799100 @default.
• W4387500514 cites W2792805205 @default.
• W4387500514 cites W2807027774 @default.
• W4387500514 cites W2886932233 @default.
• W4387500514 cites W2908548900 @default.
• W4387500514 cites W2929349817 @default.
• W4387500514 cites W2941230975 @default.
• W4387500514 cites W2970684805 @default.
• W4387500514 cites W2986540808 @default.
• W4387500514 cites W3022334877 @default.
• W4387500514 cites W3025429080 @default.
• W4387500514 cites W4210393209 @default.
• W4387500514 cites W78649709 @default.
• W4387500514 doi "https://doi.org/10.3389/fneur.2023.1265789" @default.
• W4387500514 hasPublicationYear "2023" @default.
• W4387500514 type Work @default.
• W4387500514 citedByCount "0" @default.
• W4387500514 crossrefType "journal-article" @default.
• W4387500514 hasAuthorship W4387500514A5016606411 @default.
• W4387500514 hasAuthorship W4387500514A5034379204 @default.
• W4387500514 hasAuthorship W4387500514A5081920815 @default.
• W4387500514 hasBestOaLocation W43875005141 @default.
• W4387500514 hasConcept C118552586 @default.
• W4387500514 hasConcept C126322002 @default.
• W4387500514 hasConcept C138496976 @default.
• W4387500514 hasConcept C15744967 @default.
• W4387500514 hasConcept C168563851 @default.
• W4387500514 hasConcept C1862650 @default.
• W4387500514 hasConcept C2776245837 @default.
• W4387500514 hasConcept C2776478404 @default.
• W4387500514 hasConcept C2778182776 @default.
• W4387500514 hasConcept C2779134260 @default.
• W4387500514 hasConcept C2779734285 @default.
• W4387500514 hasConcept C2781210498 @default.
• W4387500514 hasConcept C2983189541 @default.

• next